Clinical Trial Detail

NCT ID NCT03864042
Title Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Array BioPharma
Indications

melanoma

skin melanoma

Advanced Solid Tumor

Therapies

Caffeine + Dextromethorphan + Losartan + Midazolam + Omeprazole

Modafinil

Bupropion + Rosuvastatin

Binimetinib + Encorafenib

Age Groups: senior adult

Additional content available in CKB BOOST